Concepedia

Hendrick-Tobias Arkenau

HA

Statistics

Publications

2

Citations

550

H-Index

2

Active since

2014

Affiliations

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center(Current)

Hendrick-Tobias Arkenau is an author at University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center specializing in non-small cell lung cancer treatment, lung cancer, and non-small cell lung cancer therapy.

Publications per year

2014–2019

2

Publications

2

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

Alexander Drilon, Salvatore Siena, Rafał Dziadziuszko et al. · The Lancet Oncology · 2019 · 537 citations · Full text

, , +15

506 Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer

Jasgit C. Sachdev, Hendrick-Tobias Arkenau, J. R. Infante et al. · European Journal of Cancer · 2014 · 13 citations

, , +14

1–2 of 2